vs
CarParts.com, Inc.(PRTS)与Tarsus Pharmaceuticals, Inc.(TARS)财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是CarParts.com, Inc.的1.3倍($151.7M vs $120.4M),Tarsus Pharmaceuticals, Inc.净利率更高(-5.5% vs -9.6%,领先4.1%),Tarsus Pharmaceuticals, Inc.同比增速更快(128.4% vs -9.8%),过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高(134.4% vs -8.6%)
GPC是一家总部位于美国佐治亚州亚特兰大的汽车与工业零部件分销商,1928年由弗雷泽兄弟创立,目前拥有约六万名员工。除美国本土市场外,公司业务还覆盖澳大拉西亚、比利时、加拿大、法国、德国、墨西哥、荷兰、波兰及英国,旗下拥有知名汽车零部件零售商NAPA Auto Parts和工业零部件分销商Motion。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司,专注于眼科、皮肤科等专科领域创新疗法的研发和商业化,主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症,核心市场为美国。
PRTS vs TARS — 直观对比
营收规模更大
TARS
是对方的1.3倍
$120.4M
营收增速更快
TARS
高出138.2%
-9.8%
净利率更高
TARS
高出4.1%
-9.6%
两年增速更快
TARS
近两年复合增速
-8.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $120.4M | $151.7M |
| 净利润 | $-11.6M | $-8.4M |
| 毛利率 | 33.2% | — |
| 营业利润率 | — | -5.3% |
| 净利率 | -9.6% | -5.5% |
| 营收同比 | -9.8% | 128.4% |
| 净利润同比 | 25.0% | 63.8% |
| 每股收益(稀释后) | $-0.82 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PRTS
TARS
| Q4 25 | $120.4M | $151.7M | ||
| Q3 25 | $127.8M | $118.7M | ||
| Q2 25 | $151.9M | $102.7M | ||
| Q1 25 | $147.4M | $78.3M | ||
| Q4 24 | $133.5M | $66.4M | ||
| Q3 24 | $144.8M | $48.1M | ||
| Q2 24 | $144.3M | $40.8M | ||
| Q1 24 | — | $27.6M |
净利润
PRTS
TARS
| Q4 25 | $-11.6M | $-8.4M | ||
| Q3 25 | $-10.9M | $-12.6M | ||
| Q2 25 | $-12.7M | $-20.3M | ||
| Q1 25 | $-15.3M | $-25.1M | ||
| Q4 24 | $-15.4M | $-23.1M | ||
| Q3 24 | $-10.0M | $-23.4M | ||
| Q2 24 | $-8.7M | $-33.3M | ||
| Q1 24 | — | $-35.7M |
毛利率
PRTS
TARS
| Q4 25 | 33.2% | — | ||
| Q3 25 | 33.1% | — | ||
| Q2 25 | 32.8% | — | ||
| Q1 25 | 32.1% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | 33.5% | — | ||
| Q1 24 | — | — |
营业利润率
PRTS
TARS
| Q4 25 | — | -5.3% | ||
| Q3 25 | -7.9% | -12.2% | ||
| Q2 25 | -8.2% | -21.6% | ||
| Q1 25 | -10.3% | -33.5% | ||
| Q4 24 | -11.6% | -36.8% | ||
| Q3 24 | -6.9% | -52.3% | ||
| Q2 24 | -6.0% | -81.6% | ||
| Q1 24 | — | -136.5% |
净利率
PRTS
TARS
| Q4 25 | -9.6% | -5.5% | ||
| Q3 25 | -8.5% | -10.6% | ||
| Q2 25 | -8.4% | -19.8% | ||
| Q1 25 | -10.4% | -32.1% | ||
| Q4 24 | -11.5% | -34.8% | ||
| Q3 24 | -6.9% | -48.7% | ||
| Q2 24 | -6.0% | -81.6% | ||
| Q1 24 | — | -129.4% |
每股收益(稀释后)
PRTS
TARS
| Q4 25 | $-0.82 | $-0.17 | ||
| Q3 25 | $-0.19 | $-0.30 | ||
| Q2 25 | $-0.23 | $-0.48 | ||
| Q1 25 | $-0.27 | $-0.64 | ||
| Q4 24 | $-0.28 | $-0.57 | ||
| Q3 24 | $-0.17 | $-0.61 | ||
| Q2 24 | $-0.15 | $-0.88 | ||
| Q1 24 | — | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $25.8M | $417.3M |
| 总债务越低越好 | — | $72.4M |
| 股东权益账面价值 | $53.5M | $343.4M |
| 总资产 | $184.9M | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势,按日历期对齐
现金及短期投资
PRTS
TARS
| Q4 25 | $25.8M | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | — | $381.1M | ||
| Q1 25 | — | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | — | $323.6M | ||
| Q1 24 | — | $298.5M |
总债务
PRTS
TARS
| Q4 25 | — | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $71.6M | ||
| Q1 24 | — | $29.9M |
股东权益
PRTS
TARS
| Q4 25 | $53.5M | $343.4M | ||
| Q3 25 | $64.2M | $335.1M | ||
| Q2 25 | $62.4M | $332.6M | ||
| Q1 25 | $72.8M | $342.5M | ||
| Q4 24 | $85.2M | $224.5M | ||
| Q3 24 | $97.2M | $237.5M | ||
| Q2 24 | $103.9M | $252.2M | ||
| Q1 24 | — | $275.2M |
总资产
PRTS
TARS
| Q4 25 | $184.9M | $562.2M | ||
| Q3 25 | $200.3M | $534.6M | ||
| Q2 25 | $189.6M | $495.0M | ||
| Q1 25 | $216.5M | $500.8M | ||
| Q4 24 | $210.6M | $377.0M | ||
| Q3 24 | $227.6M | $376.3M | ||
| Q2 24 | $238.0M | $376.8M | ||
| Q1 24 | — | $349.3M |
负债/权益比
PRTS
TARS
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $13.0M |
| 自由现金流率自由现金流/营收 | — | 8.6% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.3M |
8季度趋势,按日历期对齐
经营现金流
PRTS
TARS
| Q4 25 | — | $19.3M | ||
| Q3 25 | $-6.4M | $18.3M | ||
| Q2 25 | $-25.6M | $-29.4M | ||
| Q1 25 | $5.5M | $-20.7M | ||
| Q4 24 | $1.8M | $-22.2M | ||
| Q3 24 | $8.5M | $-8.7M | ||
| Q2 24 | $-3.6M | $-14.4M | ||
| Q1 24 | — | $-37.8M |
自由现金流
PRTS
TARS
| Q4 25 | — | $13.0M | ||
| Q3 25 | $-8.3M | $16.3M | ||
| Q2 25 | $-27.9M | $-30.4M | ||
| Q1 25 | $3.4M | $-21.2M | ||
| Q4 24 | $-631.0K | $-22.3M | ||
| Q3 24 | $4.9M | $-8.9M | ||
| Q2 24 | $-10.8M | $-15.4M | ||
| Q1 24 | — | $-38.0M |
自由现金流率
PRTS
TARS
| Q4 25 | — | 8.6% | ||
| Q3 25 | -6.5% | 13.8% | ||
| Q2 25 | -18.3% | -29.6% | ||
| Q1 25 | 2.3% | -27.1% | ||
| Q4 24 | -0.5% | -33.5% | ||
| Q3 24 | 3.4% | -18.6% | ||
| Q2 24 | -7.5% | -37.8% | ||
| Q1 24 | — | -137.5% |
资本支出强度
PRTS
TARS
| Q4 25 | — | 4.2% | ||
| Q3 25 | 1.5% | 1.6% | ||
| Q2 25 | 1.5% | 1.0% | ||
| Q1 25 | 1.4% | 0.8% | ||
| Q4 24 | 1.8% | 0.1% | ||
| Q3 24 | 2.5% | 0.6% | ||
| Q2 24 | 4.9% | 2.5% | ||
| Q1 24 | — | 0.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图